<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">surgonco</journal-id><journal-title-group><journal-title xml:lang="ru">Креативная хирургия и онкология</journal-title><trans-title-group xml:lang="en"><trans-title>Creative surgery and oncology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2076-3093</issn><issn pub-type="epub">2307-0501</issn><publisher><publisher-name>Башкирский государственный медицинский университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24060/2076-3093-2017-7-4-43-47</article-id><article-id custom-type="elpub" pub-id-type="custom">surgonco-268</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ОЦЕНКА ПРОГНОСТИЧЕСКОЙ ЗНАЧИМОСТИ ПОКАЗАТЕЛЯ АКТИВНОСТИ ЭНДОТОКСИНА КРОВИ У ПАЦИЕНТОВ С СЕПСИСОМ</article-title><trans-title-group xml:lang="en"><trans-title>EVALUATION OF PROGNOSTIC SIGNIFICANCE OF BLOOD ENDOTOXIN ACTIVITY INDICATOR IN PATIENTS WITH SEPSIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Золотухин</surname><given-names>К. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Zolotukhin</surname><given-names>Konstantin N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Золотухин Константин Николаевич - к.м.н., заведующий отделением АРО1,</p><p>450005, Уфа, ул. Достоевского, 132</p></bio><bio xml:lang="en"><p>Zolotukhin Konstantin Nikolaevich - Candidate of Medical Sciences, Chief of ICU &amp; Anesthesiology Department, G.G. Kuvatov Republican Clinical Hospital.</p><p>132 Dostoevsky st., Ufa, 450005.</p></bio><email xlink:type="simple">lkbros5@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кронфельднер</surname><given-names>Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Kronfeldner</surname><given-names>Helmut</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кронфельднер Гельмут - врач отделения анестезиологии Университетской клиники Регенсбурга, </p><p>93051, Регенсбург, проспект Франца-Йозефа-Штрауса, 11</p></bio><bio xml:lang="en"><p>Kronfeldner Helmut - Dr. med., Physician of the Department of Anesthesiology at University Hospital Regensburg.</p><p>Franz-Josef-Strauss-Allee 11, 93051 Regensburg.</p></bio><email xlink:type="simple">helmut.kronfeldner@ukr.de</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9302-499X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самородов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Samorodov</surname><given-names>Aleksandr</given-names></name></name-alternatives><bio xml:lang="ru"><p>Самородов Александр Владимирович - к.м.н., врач анестезиолог-реаниматолог АРО1 ГБУЗ РКБ им. Г.Г. Куватова, </p><p>450005, Уфа, ул. Достоевского, 132</p></bio><bio xml:lang="en"><p>Samorodov Aleksandr Vladimirovich – Candidate of Medical Sciences, Physician of the Department of ICU &amp; Anesthesiology, G.G. Kuvatov Republican Clinical Hospital.</p><p>132 Dostoevsky st., Ufa, 450005.</p></bio><email xlink:type="simple">AVSamorodov@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Республиканская клиническая больница им. Г.Г. Куватова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>G.G. Kuvatov Republican Clinical Hospital.</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Клиника Университета Регенсбурга</institution><country>Германия</country></aff><aff xml:lang="en"><institution>University Hospital Regensburg.</institution><country>Germany</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2017</year></pub-date><pub-date pub-type="epub"><day>09</day><month>12</month><year>2017</year></pub-date><volume>7</volume><issue>4</issue><fpage>43</fpage><lpage>47</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Золотухин К.Н., Кронфельднер Г., Самородов А.В., 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="ru">Золотухин К.Н., Кронфельднер Г., Самородов А.В.</copyright-holder><copyright-holder xml:lang="en">Zolotukhin K.N., Kronfeldner H., Samorodov A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surgonco.ru/jour/article/view/268">https://www.surgonco.ru/jour/article/view/268</self-uri><abstract><sec><title>Введение</title><p>Введение. Лабораторная оценка эндотоксинемии, совместно с клинической кар - тиной, уже достаточно давно используется в качестве критериев диагностики сепсиса. Однако, на сегодняшний день недостаточно данных, позволяющих оценить прогностическую эффективность теста активности эндотоксина.</p><p>Цель исследования - анализ прогностической значимости показателя активности эндотоксина у пациентов с сепсисом, находящихся на лечении в условиях отделения хирургической реанимации и интенсивной терапии многопрофильного стационара.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. В рамках одноцентрового проспективного исследования на базе анастезиолого-реанимационного отделения №1 ГБУЗ РКБ им. Г.Г. Куватова (г. Уфа) в период октябрь 2015 - май 2016 года проведен скрининг 60 пациентов с сепсисом и 15 здоровых добровольцев.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что медиана значения активности эндотоксина в группе больных сепсисом составила 0,42 против 0,1 группы здоровых добровольцев. Уровень активности эндотоксина коррелирует с тяжестью заболевания: низкие баллы по шкале тяжести состояния APACHE II соответствовали низким показателям активности эндотоксина (r=0.985, r2=0.971, p=0.0001). Медиана чувствительности диагностического теста соответствует 87,5%, а специфичности - 32,6%. Прогностическая ценность положительного результата составила 27,5% (вероятность наличия инвазии грамотрицательной флоры у пациента с положительным результатом теста), а прогностическая ценность отрицательного результата — 97,8% (вероятность отсутствия инвазии грамотрицательной флоры у пациента с отрицательным результатом теста). Оценка прогностической роли в развитии септического шока демострирует: площадь под ROC – кривой для уровня активности эндотоксина оказалась равной 0,749±0,084, 95% доверительный интервал (ДИ) 0,620 - 0,852. Чувствительность – 61,5% (54,8-86,0), специфичность – 93,6% (82,4-98,6). Оптимальная точка разделения составила 0,88. Положительный предсказывающий уровень составил 72,7%, отрицательный 89,8%.</p></sec><sec><title>Заключение</title><p>Заключение. Таким образом, установлено, что высокий уровень эндотоксинемии является предиктором развития тяжелого сепсиса/септического шока, органных дисфункций, высокой летальности. Тест определения уровня активности эндотоксина крови обладает высокой чувствительностью и негативной прогностической ценностью, что позволяет использовать его в качестве эффективного скринингового метода оценки вероятной инвазии грамотрицательной флоры до получения результатов бактериологических исследований. </p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. Laboratory indicators of endotoxinemia in conjunction with the clinical picture have been used as the criteria to diagnosticate sepsis for quite a long time. The objective of the study is to analyze the prognostic significance of endotoxin activity indicator in patients with sepsis that undergo treatment in conditions of surgical resuscitation and intensive care at multidisciplinary hospital.</p></sec><sec><title>Materials and methods</title><p> Materials and methods. One-center prospective study on the basis of ICU department of the Republic Clinical Hospital (Ufa, Russia) during the period of 2015- 2016. We have performed screening of 60 patients with sepsis and 15 healthy volunteers.</p></sec><sec><title>Results</title><p> Results. The median of the value of endotoxin activity in group of patients with sepsis amounted to 0.42 vs. 0.1 of group of healthy volunteers. It was found that the level of endotoxin activity correlates with the severity of the disease: low scores on the scale of the APACHE II severity are consistent with low endotoxin activity (r=0.985, r2=0.971, p=0.0001). Findings show that the median of sensitivity of the medical test corresponds to 87.5% and that of specificity - to 32.6%. The prognostic value of a positive result amounted to 27.5%, and the prognostic value of a negative result - 97.8%. The area under the ROC-curve for the level of endotoxin activity is equal to 0.749±0.084, 95% confidence interval (CI) 0.620-0.852. Sensitivity-61.5% (54.8-86.0), specificity is 93.6% (82.4-98.6). The optimum point of separation was 0.88. Positive predictive level amounted to 72.7%, negative one - 89.8%.</p></sec><sec><title>Conclusions</title><p>Conclusions. The test to determine the level of endotoxin activity of blood has high sensitivity and negative prognostic value, allowing you to use it as an effective screening method to assess the probable invasion of gram-negative flora, days before the results of bacteriological research are available. </p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>липополисахарид А</kwd><kwd>эндотоксинемия</kwd><kwd>сепсис</kwd><kwd>септический шок</kwd><kwd>предиктор</kwd></kwd-group><kwd-group xml:lang="en"><kwd>lipopolysaccharide A</kwd><kwd>endotoxinemia</kwd><kwd>sepsis</kwd><kwd>septic shock</kwd><kwd>predictor</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hartman M.E., Saeed M.J., Powell K.N., Olsen M.A. The comparative epidemiology of pediatric severe sepsis. J Intensive Care Med. 2017. 1:885066617735783. DOI: 10.1177/0885066617735783.</mixed-citation><mixed-citation xml:lang="en">Hartman M.E., Saeed M.J., Powell K.N., Olsen M.A. The comparative epidemiology of pediatric severe sepsis. J Intensive Care Med. 2017. 1:885066617735783. DOI: 10.1177/0885066617735783.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10. PMID: 11445675.</mixed-citation><mixed-citation xml:lang="en">Angus D.C., Linde-Zwirble W.T., Lidicker J., Clermont G., Carcillo J., Pinsky M.R. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29(7):1303-10. PMID: 11445675.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Yusef D., Shalakhti T., Awad S., Algharaibeh H., Khasawneh W. Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: a retrospective review. Pediatr Neonatol. 2017; Jun 9. pii:S1875-9572(16)30157-7. DOI: 10.1016/j.pedneo.2017.06.001.</mixed-citation><mixed-citation xml:lang="en">Yusef D., Shalakhti T., Awad S., Algharaibeh H., Khasawneh W. Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: a retrospective review. Pediatr Neonatol. 2017; Jun 9. pii:S1875-9572(16)30157-7. DOI: 10.1016/j.pedneo.2017.06.001.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chatterjee S., Bhattacharya M., Todi SK. Epidemiology of adult-population sepsis in India: a single center 5 year experience. Indian J Crit Care Med. 2017;21(9):573-577. DOI: 10.4103/ijccm.IJCCM_240_17.</mixed-citation><mixed-citation xml:lang="en">Chatterjee S., Bhattacharya M., Todi SK. Epidemiology of adult-population sepsis in India: a single center 5 year experience. Indian J Crit Care Med. 2017;21(9):573-577. DOI: 10.4103/ijccm.IJCCM_240_17.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J., Li Y., Sun H. Lipopolysaccharide. A target for the development of novel drugs being aimed at gram-negative bacteria. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2015;32(4):910-3. PMID: 26710468.</mixed-citation><mixed-citation xml:lang="en">Wang J., Li Y., Sun H. Lipopolysaccharide. A target for the development of novel drugs being aimed at gram-negative bacteria. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2015;32(4):910-3. PMID: 26710468.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Wang H., Wang T., Yuan Z., Cao Y., Zhou Y., He J., et al. Role of receptor for advanced glycation and products in regulating lung fluid balance in lipopolysaccharide-induced acute lung injury and infection-related acute respiratory distress syndrome. Shock. 2017; Oct. 16. DOI: 10.1097/SHK.0000000000001032.</mixed-citation><mixed-citation xml:lang="en">Wang H., Wang T., Yuan Z., Cao Y., Zhou Y., He J., et al. Role of receptor for advanced glycation and products in regulating lung fluid balance in lipopolysaccharide-induced acute lung injury and infection-related acute respiratory distress syndrome. Shock. 2017; Oct. 16. DOI: 10.1097/SHK.0000000000001032.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mai N., Prifti L., Rininger A., Bazarian H., Halterman M.W. Endotoxemia induces lung-brain coupling and multi-organ injury following cerebral ischemia-reperfusion. Exp Neurol. 2017;297:82-91. DOI: 10.1016/j.expneurol.2017.07.016.</mixed-citation><mixed-citation xml:lang="en">Mai N., Prifti L., Rininger A., Bazarian H., Halterman M.W. Endotoxemia induces lung-brain coupling and multi-organ injury following cerebral ischemia-reperfusion. Exp Neurol. 2017;297:82-91. DOI: 10.1016/j.expneurol.2017.07.016.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Marshall J.C., Foster D., Vincent J.L., Cook D.J., Dellinger R.P., Opal S., et al. Diagnostics and prognostic implications of endotoxemia in critically illness: results of the MEDIC study. J Infect Dis. 2004;190(3):527-34. DOI: 10.1086/422254.</mixed-citation><mixed-citation xml:lang="en">Marshall J.C., Foster D., Vincent J.L., Cook D.J., Dellinger R.P., Opal S., et al. Diagnostics and prognostic implications of endotoxemia in critically illness: results of the MEDIC study. J Infect Dis. 2004;190(3):527-34. DOI: 10.1086/422254.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Peters A.L., Gerritsen M.G., Brinkman P., Zwinderman K.A.H., Vlaar A.P.J., Bos LD. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. J Breath Res. 2017;11(2):026003. DOI: 10.1088/17527163/aa6545.</mixed-citation><mixed-citation xml:lang="en">Peters A.L., Gerritsen M.G., Brinkman P., Zwinderman K.A.H., Vlaar A.P.J., Bos LD. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers. J Breath Res. 2017;11(2):026003. DOI: 10.1088/17527163/aa6545.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., et al. The Third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10. DOI: 10.1001/jama.2016.0287.</mixed-citation><mixed-citation xml:lang="en">Singer M., Deutschman C.S., Seymour C.W., Shankar-Hari M., Annane D., Bauer M., et al. The Third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10. DOI: 10.1001/jama.2016.0287.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
